Evotec eliminates the handoff delays that cost sponsors 3–6 months between preclinical and clinical phases. By uniting scientific expertise, strategic regulatory insight, and seamless clinical execution within a single integrated platform, we provide direct access to Clinical Operations, Regulatory Strategy, and Quantitative Sciences alongside ADME, Bioanalysis, and Biomarker capabilities – all coordinated through one partner, one governance structure, one accountability point.

Download our Factsheet to learn more